@jjaramillo
We note your comment. We agree that the subject line character limits does not allow for the inclusion of the fair balance, but we do not agree that the main issue is the "promotion" of the subject line. Rather, the trial name "LUNGBREAK" insinuates the therapeutic area that the medication may treat. Subject lines should not contain the brand name of the product and the trial name if it eludes to the broader range of the health conditions that it may treat. (s.2.10)
We will revise to remove the trial name from the subject names.